Cybin Inc. (NEO:CYBN | NYSE AMERICAN:CYBN), a biopharmaceutical company focused on progressing “Psychedelics to TherapeuticsTM”, announced that it...
In addition to California, Oregon & Washington state hot spots, at least 21 other states are stepping up discussions about decriminalization. The post...
VANCOUVER, British Columbia, Sept. 21, 2022 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCQB: AGNPF) (the “Company”...
Advocates for the initiative, including two retired generals, say that the proposed inter-agency federal task force would support a thoughtful and coordinated...
Optimind Pharma Corp. (CSE: OMND) an emerging provider of psychedelic therapies focused on improving the everyday quality of life for individuals who suffer...
San Francisco, unsurprisingly, has become the next American city to decriminalize psychedelics. They are following the lead of over a dozen other cities...
Najla Guthrie, the Founder of the Women in Psychedelics Network joins host Margaret Williamson in this important conversation about equity, equality, and...
XPhyto Therapeutics Corp. (CSE:XPHY | OTCQB:XPHYF | FSE:4XT) is pleased to report that it has filed a patent application for a significant library of...
Xpira Pharmaceuticals is one step closer to commercializing a treatment for anorexia that uses psilocybin. The post Psilocybin For Anorexia Gets FDA Study...
LAS VEGAS, NV, Sept. 20, 2022 (GLOBE NEWSWIRE) -- PSYC Corporation (OTCPink: PSYC) (“PSYC” or the “Company”), a media leader focused on the emerging...